Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

relmada-therapeutics-(rlmd)-gains-on-positive-analyst-coverage

Relmada Therapeutics (RLMD) Gains on Positive Analyst Coverage

Mar 24, 2026

Shares of Relmada Therapeutics (RLMD) rose after Piper Sandler initiated coverage with an Overweight rating, highlighting the potential…

Read more
bank-of-america-maintains-buy-on-carvana-co.-(cvna)-march-24,-2026

Bank of America Maintains Buy on Carvana Co. (CVNA) March 24, 2026

Mar 24, 2026

Bank of America Securities maintained its Buy rating on Carvana Co. (CVNA) on March 24, 2026. This CVNA…

Read more
fresenius-se-&-co-kgaa-stock-rises-1.8%-on-xetra-amid-positive-analyst-coverage-and-biosimilar-pate

Fresenius SE & Co. KGaA stock rises 1.8% on XETRA amid positive analyst coverage and biosimilar pate

Mar 24, 2026

The Fresenius SE & Co. KGaA stock (ISIN: DE0005785604) climbed 1.8% to 44.46 EUR on XETRA on March…

Read more
epd-receives-new-analyst-coverage-with-a-hold-rating-at-$36

EPD Receives New Analyst Coverage with a Hold Rating at $36

Mar 24, 2026

Key Takeaways Truist Securities initiates coverage on Enterprise Products Partners (EPD) with a Hold rating. New price target…

Read more
albertsons-companies-sees-varied-analyst-ratings,-price-targets

Albertsons Companies Sees Varied Analyst Ratings, Price Targets

Mar 24, 2026

Got story updates? Submit your updates here. › Albertsons Companies, Inc. (NYSE:ACI) has received a ‘Hold’ consensus rating…

Read more
this-kb-home-analyst-begins-coverage-on-a-bullish-note;-here-are-top-4-initiations-for-tuesday-–-generate-biomedicines-(nasdaq:genb),-kb-home-(nyse:kbh)

This KB Home Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday – Generate Biomedicines (NASDAQ:GENB), KB Home (NYSE:KBH)

Mar 24, 2026

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
immunitybio-shares-surge-on-analyst-endorsement-and-expanded-market-access

ImmunityBio Shares Surge on Analyst Endorsement and Expanded Market Access

Mar 24, 2026

ImmunityBio shares surged 11% on a BTIG Buy rating and a key NCCN guideline inclusion for its cancer…

Read more
uber-technologies,-inc-($uber)-ceo-&-director-2025-pay-revealed

Uber Technologies, Inc ($UBER) CEO & Director 2025 Pay Revealed

Mar 24, 2026

By: Quiver InsiderRadar, Automated Posted: 6 hours ago / March 23, 2026 9:26 p.m. UTC We estimate that the…

Read more
truist-initiates-williams-companies-stock-coverage-with-buy-rating

Truist initiates Williams Companies stock coverage with buy rating

Mar 23, 2026

Truist initiates Williams Companies stock coverage with buy rating

Read more
truist-initiates-viper-energy-stock-coverage-with-buy-rating

Truist initiates Viper Energy stock coverage with buy rating

Mar 23, 2026

Truist initiates Viper Energy stock coverage with buy rating

Read more
truist-initiates-kinder-morgan-stock-coverage-with-hold-rating

Truist initiates Kinder Morgan stock coverage with hold rating

Mar 23, 2026

Truist initiates Kinder Morgan stock coverage with hold rating

Read more
smithfield-foods-likely-to-report-higher-q4-earnings;-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call

Smithfield Foods Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Mar 23, 2026

Smithfield Foods, Inc. (NASDAQ:SFD) will release earnings for its fourth quarter before the opening bell on Tuesday, March…

Read more
  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. ...
  10. 377
  11. »

Posts pagination

Page 1 … Page 377 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.